Glaxo's $3bn fraud payout
Drugs firm GlaxoSmithKline will pay three billion dollars (£1.9bn) in fines after admitting to the largest healthcare fraud in US history.
US health fraud costs Glaxo £1.9bn
Drugs firm GlaxoSmithKline will pay three billion dollars (£1.9bn) in fines after admitting to the largest healthcare fraud in US history.
The UK's largest pharmaceutical company was accused of bribing doctors in America to prescribe medicines for unapproved uses, with potentially dangerous side effects.
Glaxo, which is based in west London and has household names such as Lucozade and Ribena under its brand, is due to plead guilty to criminal and civil offences involving 10 drugs taken by millions of people.
More top news
-
Joe Biden vows to fight racial inequality with economic agenda
The Democratic presidential candidate may also have shown his cards on his choice of running mate.
-
Trump reverts to promoting unproven drug as coronavirus treatment
The US president also shared a post on Twitter accusing Dr Anthony Fauci of misleading the public over hydroxychloroquine.
-
What the papers say – July 29
Fears over an impending second wave of coronavirus dominates Wednesday’s front pages.